MarketPulse

endometriosis

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Absci Bolsters Clinical Expertise with Vertex Pharma Veteran as New CMO

Absci appoints Vertex Pharma veteran Dr. Ransi Somaratne as Chief Medical Officer to lead clinical development of AI-designed therapeutics, signaling execution focus.
VRTXABSIclinical developmentVertex Pharmaceuticals
GlobeNewswire Inc.GlobeNewswire Inc.··Kdventures Ab

Organon Discontinues Second Forendos Drug Candidate, KDventures Faces Total Loss

Organon discontinues second Forendo drug candidate for PCOS, eliminating all programs from 2021 acquisition. KDventures writes off remaining contingent consideration entirely.
OGNpharmaceutical developmentdrug development discontinuation